In this video from the 2014 ASH Meeting, Dr. Grupp discusses data from a trial using CAR T-cell therapy in children and young adults with relapsed, treatment-resistant ALL.
Stephan Grupp, MD, PhD
Advertisement
Articles by Stephan Grupp, MD, PhD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on CancerNetwork
1
Frontline Sunvozertinib Improves PFS vs Chemotherapy in EGFR+ NSCLC
2
The Evolution of Artificial Intelligence in Oncology: Impact on Trials, Workflows, and Outcomes
3
Considering Venlafaxine as Distress Treatment in Breast Cancer
4
FDA Clears Investigator-Initiated IND for SRN-101 in Recurrent High-Grade Glioma
5